 | • レポートコード：MRC23Q35778 • 出版社/出版日：QYResearch / 2023年3月 • レポート形態：英文、PDF、108ページ • 納品方法：Eメール（2-3日） • 産業分類：農業 |
| Single User | ￥435,000 (USD2,900) | ▷ お問い合わせ |
| Enterprise License | ￥870,000 (USD5,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは世界の動物用腸内健康市場について調査・分析し、世界の動物用腸内健康市場概要、市場トレンド、主要企業別競争状況、タイプ別セグメント分析（プロバイオティクス、プレバイオティクス、植物源、免疫賦活剤）、用途別セグメント分析（農場、動物園）、地域別市場規模、主要企業のプロファイルなどに関する情報を掲載しています。主要企業としては、Koninklijke DSM NV、Archer Daniels Midland Company、Kemin Industries、DuPont、Cargill、Novozymes、Nutreco NV、Chr. Hansen Holding A/S、Bluestar Adisseo、Alltech、Evonik Industries、Lallemand、Biorigin、AB Vista、Land O'Lakes、Lesaffre、Calpis、Unique Biotech、Pure Cultures、Dr. Eckel Animal Nutrition GmbH & Coなどが含まれています。世界の動物用腸内健康市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。COVID-19とロシア・ウクライナ戦争の影響は、動物用腸内健康市場規模を推定する際に考慮しました。本レポートは、動物用腸内健康の世界市場を定量的・定性的な分析により包括的に提示し、読者がビジネス/成長戦略を策定し、市場競争状況を把握し、現在の市場における自社のポジションを分析し、動物用腸内健康に関するビジネス上の意思決定に役立てることを目的としています。 ・動物用腸内健康市場の概要 - 動物用腸内健康のタイプ別セグメント - 世界の動物用腸内健康市場規模：タイプ別分析（プロバイオティクス、プレバイオティクス、植物源、免疫賦活剤） - 動物用腸内健康の用途別セグメント - 世界の動物用腸内健康市場規模：用途別分析（農場、動物園） - 世界の動物用腸内健康市場規模予測（2018年-2029年） ・動物用腸内健康市場の成長トレンド - 動物用腸内健康の地域別市場規模（2018年-2029年） - 動物用腸内健康市場ダイナミクス - 動物用腸内健康の業界動向 - 動物用腸内健康市場の成長ドライバ、課題、阻害要因 ・主要企業別競争状況 - 企業別市場シェア - 世界の主要企業、業界ランキング分析 - 市場への参入、M＆A動向 ・タイプ別セグメント：プロバイオティクス、プレバイオティクス、植物源、免疫賦活剤 - 世界の動物用腸内健康のタイプ別市場規模（2018年-2023年） - 世界の動物用腸内健康のタイプ別市場規模（2024年-2029年） ・用途別セグメント：農場、動物園 - 世界の動物用腸内健康の用途別市場規模（2018年-2023年） - 世界の動物用腸内健康の用途別市場規模（2024年-2029年） ・動物用腸内健康の地域別市場規模 - 北米の動物用腸内健康市場規模（2018年-2029年） - アメリカの動物用腸内健康市場規模（2018年-2029年） - ヨーロッパの動物用腸内健康市場規模（2018年-2029年） - アジア太平洋の動物用腸内健康市場規模（2018年-2029年） - 中国の動物用腸内健康市場規模（2018年-2029年） - 日本の動物用腸内健康市場規模（2018年-2029年） - 韓国の動物用腸内健康市場規模（2018年-2029年） - インドの動物用腸内健康市場規模（2018年-2029年） - オーストラリアの動物用腸内健康市場規模（2018年-2029年） - 中南米の動物用腸内健康市場規模（2018年-2029年） - 中東・アフリカの動物用腸内健康市場規模（2018年-2029年） ・主要企業のプロファイル：企業情報、事業概要、売上、動向 Koninklijke DSM NV、Archer Daniels Midland Company、Kemin Industries、DuPont、Cargill、Novozymes、Nutreco NV、Chr. Hansen Holding A/S、Bluestar Adisseo、Alltech、Evonik Industries、Lallemand、Biorigin、AB Vista、Land O'Lakes、Lesaffre、Calpis、Unique Biotech、Pure Cultures、Dr. Eckel Animal Nutrition GmbH & Co ・アナリストの観点/結論 ・調査方法とデータソース |
Highlights
The global Animal Intestinal Health market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Animal Intestinal Health is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Animal Intestinal Health is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Animal Intestinal Health in Farm is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Animal Intestinal Health include Koninklijke DSM NV, Archer Daniels Midland Company, Kemin Industries, DuPont, Cargill, Novozymes, Nutreco NV, Chr. Hansen Holding A/S and Bluestar Adisseo, etc. In 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Animal Intestinal Health, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Animal Intestinal Health.
The Animal Intestinal Health market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Animal Intestinal Health market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Animal Intestinal Health companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Koninklijke DSM NV
Archer Daniels Midland Company
Kemin Industries
DuPont
Cargill
Novozymes
Nutreco NV
Chr. Hansen Holding A/S
Bluestar Adisseo
Alltech
Evonik Industries
Lallemand
Biorigin
AB Vista
Land O’Lakes
Lesaffre
Calpis
Unique Biotech
Pure Cultures
Dr. Eckel Animal Nutrition GmbH & Co
Segment by Type
Probiotics
Prebiotics
Plant Source
Immunostimulant
Segment by Application
Farm
Zoo
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Animal Intestinal Health companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Animal Intestinal Health Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Probiotics
1.2.3 Prebiotics
1.2.4 Plant Source
1.2.5 Immunostimulant
1.3 Market by Application
1.3.1 Global Animal Intestinal Health Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Farm
1.3.3 Zoo
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Animal Intestinal Health Market Perspective (2018-2029)
2.2 Animal Intestinal Health Growth Trends by Region
2.2.1 Global Animal Intestinal Health Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Animal Intestinal Health Historic Market Size by Region (2018-2023)
2.2.3 Animal Intestinal Health Forecasted Market Size by Region (2024-2029)
2.3 Animal Intestinal Health Market Dynamics
2.3.1 Animal Intestinal Health Industry Trends
2.3.2 Animal Intestinal Health Market Drivers
2.3.3 Animal Intestinal Health Market Challenges
2.3.4 Animal Intestinal Health Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Animal Intestinal Health Players by Revenue
3.1.1 Global Top Animal Intestinal Health Players by Revenue (2018-2023)
3.1.2 Global Animal Intestinal Health Revenue Market Share by Players (2018-2023)
3.2 Global Animal Intestinal Health Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Animal Intestinal Health Revenue
3.4 Global Animal Intestinal Health Market Concentration Ratio
3.4.1 Global Animal Intestinal Health Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Animal Intestinal Health Revenue in 2022
3.5 Animal Intestinal Health Key Players Head office and Area Served
3.6 Key Players Animal Intestinal Health Product Solution and Service
3.7 Date of Enter into Animal Intestinal Health Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Animal Intestinal Health Breakdown Data by Type
4.1 Global Animal Intestinal Health Historic Market Size by Type (2018-2023)
4.2 Global Animal Intestinal Health Forecasted Market Size by Type (2024-2029)
5 Animal Intestinal Health Breakdown Data by Application
5.1 Global Animal Intestinal Health Historic Market Size by Application (2018-2023)
5.2 Global Animal Intestinal Health Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Animal Intestinal Health Market Size (2018-2029)
6.2 North America Animal Intestinal Health Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Animal Intestinal Health Market Size by Country (2018-2023)
6.4 North America Animal Intestinal Health Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Animal Intestinal Health Market Size (2018-2029)
7.2 Europe Animal Intestinal Health Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Animal Intestinal Health Market Size by Country (2018-2023)
7.4 Europe Animal Intestinal Health Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Animal Intestinal Health Market Size (2018-2029)
8.2 Asia-Pacific Animal Intestinal Health Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Animal Intestinal Health Market Size by Region (2018-2023)
8.4 Asia-Pacific Animal Intestinal Health Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Animal Intestinal Health Market Size (2018-2029)
9.2 Latin America Animal Intestinal Health Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Animal Intestinal Health Market Size by Country (2018-2023)
9.4 Latin America Animal Intestinal Health Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Animal Intestinal Health Market Size (2018-2029)
10.2 Middle East & Africa Animal Intestinal Health Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Animal Intestinal Health Market Size by Country (2018-2023)
10.4 Middle East & Africa Animal Intestinal Health Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Koninklijke DSM NV
11.1.1 Koninklijke DSM NV Company Detail
11.1.2 Koninklijke DSM NV Business Overview
11.1.3 Koninklijke DSM NV Animal Intestinal Health Introduction
11.1.4 Koninklijke DSM NV Revenue in Animal Intestinal Health Business (2018-2023)
11.1.5 Koninklijke DSM NV Recent Development
11.2 Archer Daniels Midland Company
11.2.1 Archer Daniels Midland Company Company Detail
11.2.2 Archer Daniels Midland Company Business Overview
11.2.3 Archer Daniels Midland Company Animal Intestinal Health Introduction
11.2.4 Archer Daniels Midland Company Revenue in Animal Intestinal Health Business (2018-2023)
11.2.5 Archer Daniels Midland Company Recent Development
11.3 Kemin Industries
11.3.1 Kemin Industries Company Detail
11.3.2 Kemin Industries Business Overview
11.3.3 Kemin Industries Animal Intestinal Health Introduction
11.3.4 Kemin Industries Revenue in Animal Intestinal Health Business (2018-2023)
11.3.5 Kemin Industries Recent Development
11.4 DuPont
11.4.1 DuPont Company Detail
11.4.2 DuPont Business Overview
11.4.3 DuPont Animal Intestinal Health Introduction
11.4.4 DuPont Revenue in Animal Intestinal Health Business (2018-2023)
11.4.5 DuPont Recent Development
11.5 Cargill
11.5.1 Cargill Company Detail
11.5.2 Cargill Business Overview
11.5.3 Cargill Animal Intestinal Health Introduction
11.5.4 Cargill Revenue in Animal Intestinal Health Business (2018-2023)
11.5.5 Cargill Recent Development
11.6 Novozymes
11.6.1 Novozymes Company Detail
11.6.2 Novozymes Business Overview
11.6.3 Novozymes Animal Intestinal Health Introduction
11.6.4 Novozymes Revenue in Animal Intestinal Health Business (2018-2023)
11.6.5 Novozymes Recent Development
11.7 Nutreco NV
11.7.1 Nutreco NV Company Detail
11.7.2 Nutreco NV Business Overview
11.7.3 Nutreco NV Animal Intestinal Health Introduction
11.7.4 Nutreco NV Revenue in Animal Intestinal Health Business (2018-2023)
11.7.5 Nutreco NV Recent Development
11.8 Chr. Hansen Holding A/S
11.8.1 Chr. Hansen Holding A/S Company Detail
11.8.2 Chr. Hansen Holding A/S Business Overview
11.8.3 Chr. Hansen Holding A/S Animal Intestinal Health Introduction
11.8.4 Chr. Hansen Holding A/S Revenue in Animal Intestinal Health Business (2018-2023)
11.8.5 Chr. Hansen Holding A/S Recent Development
11.9 Bluestar Adisseo
11.9.1 Bluestar Adisseo Company Detail
11.9.2 Bluestar Adisseo Business Overview
11.9.3 Bluestar Adisseo Animal Intestinal Health Introduction
11.9.4 Bluestar Adisseo Revenue in Animal Intestinal Health Business (2018-2023)
11.9.5 Bluestar Adisseo Recent Development
11.10 Alltech
11.10.1 Alltech Company Detail
11.10.2 Alltech Business Overview
11.10.3 Alltech Animal Intestinal Health Introduction
11.10.4 Alltech Revenue in Animal Intestinal Health Business (2018-2023)
11.10.5 Alltech Recent Development
11.11 Evonik Industries
11.11.1 Evonik Industries Company Detail
11.11.2 Evonik Industries Business Overview
11.11.3 Evonik Industries Animal Intestinal Health Introduction
11.11.4 Evonik Industries Revenue in Animal Intestinal Health Business (2018-2023)
11.11.5 Evonik Industries Recent Development
11.12 Lallemand
11.12.1 Lallemand Company Detail
11.12.2 Lallemand Business Overview
11.12.3 Lallemand Animal Intestinal Health Introduction
11.12.4 Lallemand Revenue in Animal Intestinal Health Business (2018-2023)
11.12.5 Lallemand Recent Development
11.13 Biorigin
11.13.1 Biorigin Company Detail
11.13.2 Biorigin Business Overview
11.13.3 Biorigin Animal Intestinal Health Introduction
11.13.4 Biorigin Revenue in Animal Intestinal Health Business (2018-2023)
11.13.5 Biorigin Recent Development
11.14 AB Vista
11.14.1 AB Vista Company Detail
11.14.2 AB Vista Business Overview
11.14.3 AB Vista Animal Intestinal Health Introduction
11.14.4 AB Vista Revenue in Animal Intestinal Health Business (2018-2023)
11.14.5 AB Vista Recent Development
11.15 Land O’Lakes
11.15.1 Land O’Lakes Company Detail
11.15.2 Land O’Lakes Business Overview
11.15.3 Land O’Lakes Animal Intestinal Health Introduction
11.15.4 Land O’Lakes Revenue in Animal Intestinal Health Business (2018-2023)
11.15.5 Land O’Lakes Recent Development
11.16 Lesaffre
11.16.1 Lesaffre Company Detail
11.16.2 Lesaffre Business Overview
11.16.3 Lesaffre Animal Intestinal Health Introduction
11.16.4 Lesaffre Revenue in Animal Intestinal Health Business (2018-2023)
11.16.5 Lesaffre Recent Development
11.17 Calpis
11.17.1 Calpis Company Detail
11.17.2 Calpis Business Overview
11.17.3 Calpis Animal Intestinal Health Introduction
11.17.4 Calpis Revenue in Animal Intestinal Health Business (2018-2023)
11.17.5 Calpis Recent Development
11.18 Unique Biotech
11.18.1 Unique Biotech Company Detail
11.18.2 Unique Biotech Business Overview
11.18.3 Unique Biotech Animal Intestinal Health Introduction
11.18.4 Unique Biotech Revenue in Animal Intestinal Health Business (2018-2023)
11.18.5 Unique Biotech Recent Development
11.19 Pure Cultures
11.19.1 Pure Cultures Company Detail
11.19.2 Pure Cultures Business Overview
11.19.3 Pure Cultures Animal Intestinal Health Introduction
11.19.4 Pure Cultures Revenue in Animal Intestinal Health Business (2018-2023)
11.19.5 Pure Cultures Recent Development
11.20 Dr. Eckel Animal Nutrition GmbH & Co
11.20.1 Dr. Eckel Animal Nutrition GmbH & Co Company Detail
11.20.2 Dr. Eckel Animal Nutrition GmbH & Co Business Overview
11.20.3 Dr. Eckel Animal Nutrition GmbH & Co Animal Intestinal Health Introduction
11.20.4 Dr. Eckel Animal Nutrition GmbH & Co Revenue in Animal Intestinal Health Business (2018-2023)
11.20.5 Dr. Eckel Animal Nutrition GmbH & Co Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details